Despite an overwhelming body of literature demonstrating that MDG is extremely safe and effective for the treatment of mild to moderate hypoglycemia in T1D, glucagon is not yet FDA approved for use in this manner for this indication. This evidence concerns the gene GCG and type 1 diabetes mellitus.